Allison Aubrey
Allison Aubrey is a correspondent for NPR News, where her stories can be heard on Morning Edition and All Things Considered.She's also a contributor to the PBS NewsHour and is one of the hosts of NPR's Life Kit.
Along with her NPR science desk colleagues, Aubrey is the winner of a 2019 Gracie Award. She is the recipient of a 2018 James Beard broadcast award for her coverage of 'Food As Medicine.' Aubrey is also a 2016 winner of a James Beard Award in the category of "Best TV Segment" for a PBS/NPR collaboration. The series of stories included an investigation of the link between pesticides and the decline of bees and other pollinators, and a two-part series on food waste. In 2013, Aubrey won a Gracie Award with her colleagues on The Salt, NPR's food vertical. They also won a 2012 James Beard Award for best food blog. In 2009, Aubrey was awarded the American Society for Nutrition's Media Award for her reporting on food and nutrition. She was honored with the 2006 National Press Club Award for Consumer Journalism in radio and earned a 2005 Medical Evidence Fellowship by the Massachusetts Institute of Technology and the Knight Foundation. In 2009-2010, she was a Kaiser Media Fellow.
Joining NPR in 2003 as a general assignment reporter, Aubrey spent five years covering environmental policy, as well as contributing to coverage of Washington, D.C., for NPR's National Desk. She also hosted NPR's Tiny Desk Kitchen video series.
Before coming to NPR, Aubrey was a reporter for the PBS NewsHour and a producer for C-SPAN's Presidential election coverage.
Aubrey received her Bachelor of Arts degree from Denison University in Granville, Ohio, and a Master of Arts degree from Georgetown University in Washington, D.C.
-
New COVID-19 cases are declining significantly. And amid widespread optimism that the vaccines can help end the pandemic, states scramble to get the shots into more arms, after a very bumpy start.
-
On Tuesday, it will be a year since the first case of COVID-19 was reported in the U.S. Now there are almost 24 million cases and nearly 400,000 people are dead.
-
As the pandemic rages on, the U.S. faces a dual challenge. To speed up delivery of vaccines to those who are waiting. And to convince people who are hesitant about the importance of being vaccinated.
-
There's concern of a post holiday COVID-19 surge in cases and deaths. Plus the vaccination program is off to a slow start, and the new more contagious variant is spreading across the U.S.
-
A new coronavirus strain in the U.K. has the world on alert. In the U.S., shipments of the second COVID-19 vaccine are arriving as the CDC issues guidance on who is next in line for shots.
-
Some people who have recovered from COVID-19 have lingering symptoms. A clinic at Johns Hopkins University is helping patients get to the bottom of their ongoing mental and physical struggles.
-
The COVID-19 vaccine is on its way. What do medical directors and state officials say about their plans? None of them expect to get all the doses they need, so how do they decide who gets it first?
-
Millions of doses of the COVID-19 vaccine are arriving at distribution centers across the country. The initial batch of doses will be limited.
-
The FDA will consider Pfizer's COVID-19 vaccine on Thursday. Officials could grant approval for its emergency use immediately, and the first doses could be given later this month.
-
The colder weather ahead in much of the country, along with the spread of cases after holiday travel, means the pandemic could get worse. Still, some public health experts say schools can open.